Filing Details

Accession Number:
0001181431-11-022486
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-04-05 17:00:48
Reporting Period:
2011-04-04
Filing Date:
2011-04-05
Accepted Time:
2011-04-05 17:00:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1338042 Aegerion Pharmaceuticals Inc. AEGR Pharmaceutical Preparations (2834) 202960116
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1314575 D Marc Beer C/O Aegerion Pharmaceuticals, Inc.
89 Headquarters Plaza, Suite 1212
Morristown NJ 07960
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-04-04 4,647 $16.73 110,110 No 4 P Direct
Common Stock Acquisiton 2011-04-04 1,310 $16.73 111,420 No 4 P Indirect Roth IRA
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect Roth IRA
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 105,463 Direct
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2011.
  2. This weighted average price reflects trades in multiple transactions ranging from $16.46 per share to $16.98 per share, inclusive. Full information regarding the number of shares sold at each separate price within the range noted above will be provided upon request to the SEC staff, the issuer, or any security holder of the issuer.